Johnston Charles E, Tran Dong-Phuong, McClung Anna
1Texas Scottish Rite Hospital, Dallas, Texas.
J Bone Joint Surg Am. 2017 Jun 21;99(12):1036-1042. doi: 10.2106/JBJS.16.00796.
In this study, we sought to evaluate radiographic, functional, and quality-of-life outcomes of patients who have completed growth-sparing management of early-onset scoliosis.
This prospective study involved patients with early-onset scoliosis who underwent growth-sparing treatment and either "final" fusion or observation for ≥2 years since the last lengthening procedure. Demographics, radiographic parameters, pulmonary function test (PFT) values, and scores of patient-reported assessments (Early-Onset Scoliosis Questionnaire [EOSQ] and Scoliosis Research Society [SRS]-30) were obtained. At the most recent follow-up, patients performed 2 additional functional outcome tests: step-activity monitoring and a treadmill exercise-tolerance test.
Twelve patients were evaluated as "graduates" of growth-sparing management of early-onset scoliosis (mean of 37 months since the most recent surgery). The major scoliosis curve measurement averaged 88° before treatment and 47° at the most recent follow-up. T1-S1 height increased from a mean of 22.3 cm to 34.7 cm and T1-T12 height, from 13.3 to 22.3 cm. At the most recent follow-up, the mean forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) as a percentage of the predicted volume were 52.1% and 55.3%, respectively, and were essentially unchanged from the earliest PFT that patients could perform (FEV1 = 53.8% of predicted and FVC = 53.5% of predicted). There was no difference between graduates and controls with respect to activity time or total steps in step-activity monitoring, and in the exercise-tolerance test, graduates walked at the same speed but at a higher heart rate and at a significantly higher (p <0.001) VO2 cost (rate of oxygen consumed per distance traveled). The EOSQ mean score was 102.2 of a possible 120 points, and the SRS mean score was 4.1 of a possible 5 points.
A realistic long-term goal for the management of early-onset scoliosis appears to be spine elongation and maintenance of pulmonary function at a level that is no less than the percentage of normal at initial presentation. Functional testing and patient-reported outcomes at a mean of 3 years from the last surgery suggest that activity levels were generally equal to those of controls but required greater physiologic demand. General health and physical function outcomes revealed continued impairment in these domains.
Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
在本研究中,我们试图评估完成早发性脊柱侧弯保留生长治疗的患者的影像学、功能和生活质量结果。
这项前瞻性研究纳入了接受保留生长治疗的早发性脊柱侧弯患者,自上次延长手术后,这些患者要么接受了“最终”融合手术,要么接受了至少2年的观察。收集了患者的人口统计学资料、影像学参数、肺功能测试(PFT)值以及患者报告评估的得分(早发性脊柱侧弯问卷[EOSQ]和脊柱侧弯研究学会[SRS]-30)。在最近一次随访时,患者还进行了另外两项功能结局测试:步数活动监测和跑步机运动耐力测试。
12名患者被评估为早发性脊柱侧弯保留生长治疗的“毕业”患者(自最近一次手术以来平均37个月)。主要脊柱侧弯曲线测量值在治疗前平均为88°,在最近一次随访时为47°。T1-S1高度从平均22.3厘米增加到34.7厘米,T1-T12高度从13.3厘米增加到22.3厘米。在最近一次随访时,1秒用力呼气量(FEV1)和用力肺活量(FVC)占预测值的百分比分别为52.1%和55.3%,与患者能够进行的最早PFT相比基本没有变化(FEV1 = 预测值的53.8%,FVC = 预测值的53.5%)。在步数活动监测中的活动时间或总步数方面,“毕业”患者与对照组之间没有差异,在运动耐力测试中,“毕业”患者行走速度相同,但心率更高,且每行走单位距离的耗氧量(VO2成本)显著更高(p <0.001)。EOSQ平均得分为120分制中的102.2分,SRS平均得分为5分制中的4.1分。
早发性脊柱侧弯治疗的一个现实长期目标似乎是脊柱延长以及将肺功能维持在不低于初始表现时正常水平百分比的程度。距离上次手术平均3年时的功能测试和患者报告结局表明,活动水平总体上与对照组相当,但生理需求更大。总体健康和身体功能结局显示这些领域仍存在损害。
治疗性IV级。有关证据水平的完整描述,请参阅作者指南。